Author:
Winnette Randall,Zárate Victor,Machnicki Gerardo,DeMuro Carla,Gawlicki Mary,Gnanasakthy Ari
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference30 articles.
1. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry. Patient Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. US Dep Heal Hum Serv Food Drug Adm; 2009. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. [Accessed December 12, 2013]
2. Patient reported outcomes: looking beyond the label claim;Doward;Health Qual Life Outcomes,2010
3. Health economics and outcomes research within drug development: challenges and opportunities for reimbursement and market access within biopharma research;van Nooten;Drug Discov Today,2012
4. Integration of patient-reported outcomes in multiregional confirmatory clinical trials;Gnanasakthy;Contemp Clin Trials,2013
5. Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium;Chan;Transplantation,2006
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献